MT Newswires
Deutsche Bank Raises Price Target on McKesson to $904 From $861, Keeps Buy Rating
📊
AI Sentiment
Positive
7/10
- Home
- MCK
as of 12-10-2025 3:44pm EST
$815.05
+$20.04
+2.52%
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Chart Type:
Time Range:
| Founded: | 1833 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 107.4B | IPO Year: | N/A |
| Target Price: | $882.69 | AVG Volume (30 days): | 856.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 32.12 | EPS Growth: | 66.19 |
| 52 Week Low/High: | $558.13 - $895.58 | Next Earning Date: | 11-05-2025 |
| Revenue: | $387,094,000,000 | Revenue Growth: | 17.23% |
| Revenue Growth (this year): | 14.87% | Revenue Growth (next year): | 8.32% |
AI-Powered MCK Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 68.63%
68.63%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of McKesson Corporation (MCK)
Rutledge Napoleon B JR
Sell
SVP, Controller & CAO
MCK Nov 7, 2025
Avg Cost/Share
$861.63
Shares
329
Total Value
$283,476.27
Owned After
328
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Rutledge Napoleon B JR | MCK | SVP, Controller & CAO | Nov 7, 2025 | Sell | $861.63 | 329 | $283,476.27 | 328 |
Latest McKesson Corporation News
MCK Breaking Stock News: Dive into MCK Ticker-Specific Updates for Smart Investing
Newsfile
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
📈
AI Sentiment
Highly Positive
9/10
StockStory
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off
📊
AI Sentiment
Positive
7/10
Simply Wall St.
McKesson's (NYSE:MCK) earnings growth rate lags the 37% CAGR delivered to shareholders
📈
AI Sentiment
Highly Positive
8/10
Compare MCK vs Leading Stocks
See how MCK stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MCK McKesson Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.